Researchers analyze Xywav and Xyrem’s population pharmacokinetic and exposure-responses, shining light on the dosing and titration of oxybates.
Read More
Alkermes discusses the development, clinical trials, and safety of its orexin 2 receptor agonist drug candidate for narcolepsy and idiopathic hypersomnia.
Read More
A study suggests that a way to improve the salty taste of once-nightly sodium oxybate could be found in patients’ refrigerators.
Read More
A cross-continental collaboration improves access to pediatric sleep health diagnosis and therapy in India.
Read More
Psychologists get surprising insights into their patients’ sleeplessness when they monitor them regularly.
Read More